RIO DE JANEIRO BRAZIL - President Jair Bolsonaro spoke today, June 24, about the process of acquiring Covaxin, a Covid-19 vaccine from India's Bharat Biotech, now the target of an investigation by the Brazilian Senate's Covid CPI after a denunciation of irregularities by federal deputy Luis Miranda and his brother, Luis Ricardo Miranda, an employee of the Ministry of Health.
Bolsonaro classified the story that appeared in the press as a "fabrication" and denied any act of corruption in his government. Yesterday, the secretary-general of the presidency, Onyx Lorenzoni, announced that the Subscribe to our Premium Membership Plan. Already Subscribed? Login Here